Reformulary Group launches medical cannabis formulary
The Reformulary Group Inc. is launching the Cannabis Standard, an evidence-based medical marijuana formulary and research platform that operates on a subscription basis. It determines if patients…
- By: Staff
- April 12, 2019 November 30, 2020
- 15:15












